NFATC2 Variation Linked to Rosiglitazone-induced Edema

MedWire News: Variation in the NFATC2 (nuclear factor of activated T-cells cytoplasmic calcineurin-dependent 2) gene is associated with increased risk for rosiglitazone-associated edema, show results from a subanalysis of the DREAM trial.